Urethral Recurrence of Bladder Tumor Occurring as a Perineal Mass 2 Years After Transurethral Resection: A Case Report  by Ergün, Osman et al.
Kaohsiung J Med Sci November 2010 • Vol 26 • No 11624
© 2010 Elsevier. All rights reserved.
Transitional cell carcinoma (TCC) can develop as a mul-
tifocal tumor in the urinary system, especially in the
bladder [1]. The possible causes of synchronous and
asynchronous anterior urethral TCC development in
bladder TCC patients, who have been treated with
the orthotopic new bladder procedure, have been dis-
cussed in several reports in the literature [2–5]. Anterior
urethral TCC recurrence after cystectomy has been re-
ported in 4–17% of patients. Multifocal cancers, concur-
rent upper urinary tract tumors, diffuse carcinoma 
in situ (CIS), involvement of the bladder neck or trigone,
involvement of the prostatic urethra or deep prostatic
invasion, and positive urethral margins on intraopera-
tive frozen sections are associated with increased risk
of urethral recurrence [2,4–6]. Although prophylactic
urethrectomy is recommended in these conditions,
there are still discrepancies among the studies in the
literature. Tobisu et al detected anterior urethral TCC
in 10.6% of their patients that had undergone radical
cystectomy for bladder TCC [7]. In another study, they
detected TCC in bulbar urethra in 19% of patients who
had been treated with cystourethrectomy in the pres-
ence of diffuse bladder CIS, whereas no bulbar urethral
tumor was seen in patients without diffuse CIS [8].
In our literature search, we found case reports about
the management approaches for urethral tumor recur-
rence after radical cystectomy. However, we could
not find a clear approach for the treatment of patients
who refuse radical cystectomy. The aim of the study
was to evaluate treatment options and present the clin-
ical features of an invasive bladder tumor (T2a, G3)
in a patient who refused advance treatment options
for invasive bladder tumor, and had urethral recur-
rence 2 years after transurethral resection.
CASE PRESENTATION
A 69-year-old man underwent transurethral resec-
tion for a bladder tumor in 2006. Cystoscopy during
transurethral resection showed that the tumor was
3–4 cm in diameter, localized in the left lateral wall
and projected into the lumen in a papillary forma-
tion. The tumor was resected with a 1-cm margin on
non-tumor tissue. Pathological evaluation revealed
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T2a, G3 TCC. A single dose of mitomycin C was ad-
ministered just after the operation. The patient refused
all treatment modalities for invasive bladder tumor.
Therefore, he was subjected to follow-up examina-
tion every 3 months. The patient presented to us with
obstructive lower urinary tract symptoms (LUTS) in
June 2008. Physical examination revealed a perineal
mass that the patient had recognized during the pre-
vious 2 months, which had grown rapidly since then.
This perineal mass caused obstructive LUTS and the
patient had a history of bladder tumor, therefore, we
suspected that it was a metastatic or recurrent tumor.
Whole abdominal and pelvic computed tomography
(CT) revealed a urethral mass of 3.5 × 2.0 cm (Figure
1A). Radiological examination and cystourethroscopy
did not reveal any other malignancies. Thereafter,
partial urethrectomy with perineal urethrostomy were
performed (Figure 1B). The patient did not accept
total or partial penectomy because he felt that erectile
function was the most important issue for him. The
tumor was located on the bulbar urethra. Patho-
logical examination revealed pT2 TCC of the bulbar
urethra, with dimensions of 3.8 × 2.8 × 2.5 cm (Figure
2). The surgical margin was clear but there was per-
ineuronal invasion. The patient was followed up
every 3 months. Generally, the follow-up evaluation
at each visit included a physical examination, urinary
cytology, ultrasonography, cystourethroscopy and, if
necessary, CT, bone scintigraphy and chest radio-
graphy. Physical examination, cystoscopy and ultra-
sound images were normal in follow-up examinations
at 3, 6, 9, 12 and 15 months. No pathological findings
were detected on total abdominal and pelvic CT
scans that were done at 6 months and 12 months. The
patient’s family was also persuaded to undergo
chemotherapy.
The patient was treated with combination chemo-
therapy including cisplatin because he had advanced
disease. He showed no evidence of metastasis or local
recurrence for 16 months after surgery. Postoperative
urine cytology was negative. The patient was healthy
and free of complications and recurrence at 16 months
after the operation.
DISCUSSION
Urethral malignancy accounts for <1% of male urolog-
ical malignancies. The most common histological type
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Figure 1. (A) Pelvic computed tomography shows the mass around the urethra. (B) Photograph of the perineum after surgery.
Figure 2. Histological examination of the excised tumor (hema-
toxylin and eosin, original magnification, 200×).
is squamous cell carcinoma (78%) in the anterior ure-
thra, which is lined by pseudostratified and stratified
columnar epithelium, and most distally in the mea-
tus by stratified squamous epithelium. One in five of
anterior urethral carcinomas occur in the fossa navic-
ularis. TCC usually occurs in the posterior urethra;
mainly in the prostatic portion where the epithelium
is transitional and in continuity with the bladder epi-
thelium. TCC is extremely rare in the anterior urethra.
Its occurrence in an area that is normally lined by
squamous epithelium could be explained by urothe-
lial metaplasia, urogenital tumor metastases, or the
presence of ectopic urothelium.
It is also uncommon for recurrent urethral tumor to
present as a painful perineal mass. Mass lesions that
arise in the perineum of patients who have undergone
cystectomy for urothelial carcinoma should raise sus-
picion of recurrent urothelial carcinoma. Urethral re-
currence has been reportedly identified by several
symptoms, or by cytological examination. Initial symp-
toms for urethral recurrence are obstructive LUTS,
macrohematuria, penile pain or mass, and urinary in-
continence [9,10]. The prognosis of superficial urethral
recurrence is better than that of invasive recurrence;
therefore, early detection is needed for such urethral
recurrence. Retrospective analysis of cystectomy series
has revealed a correlation between specific pathologi-
cal characteristics of bladder TCC and anterior urethral
occurrence, including tumor multiplicity, existence of
diffuse CIS, involvement of the internal urethral ori-
fice and prostatic urethra, and particularly, invasion
into the prostatic ducts or stroma. It has been reported
that 4–18% of male patients will develop recurrent
urethral TCC in the remnant urethra after cystectomy
[4,5–11]. Gowing has found CIS in the urethra in six
of 33 autopsies performed on patients who died from
bladder cancer [12]. Nieder et al observed urethral
recurrence in eight of 218 patients (3.7%) who under-
went radical cystoprostatectomy [13]. These studies
suggest the treatment procedure that should be ap-
plied in the case of urethral spread or recurrence de-
tected during or after cystectomy. However, there are
still no clear data for patients with urethral recurrence
that develops after transurethral resection for invasive
bladder tumor, even though they have normal cysto-
scopy, ultrasonography and CT results at follow-up.
Our patient underwent follow-up examination every
3 months. However, the patient presented to us with
obstructive LUTS after 2 years. Perineal mass was
detected on physical examination, and urethral recur-
rence was suspected.
Tumors of the anterior urethra distal to the bulb
are best managed by partial or total penectomy with
perineal urethrostomy. Local recurrences are rare after
such treatment. Treatment failure is a result of an un-
suspected inadequate surgical margin or undetected
regional lymph node involvement at the time of pri-
mary surgery [14]. However, our patient underwent
partial urethrectomy with perineal urethrostomy be-
cause he did not want total or even partial penectomy.
He mentioned that erectile function was the most
important factor for him. The reported 5-year survival
rate is between 50–66%. It is important to be aware
that symptoms of some benign diseases such as ure-
thral stricture, urethritis, prostatitis and prostatic en-
largement are also those of urethral malignancy. The
development of a stricture in a middle aged or elderly
man with no previous history of urethral disease, espe-
cially obstruction that bleeds easily, should arouse
suspicion of urethral malignancy [15].
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